Dr. Pang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Stanford Univ Sch of Med
Stanford, CA 94305Phone+1 650-723-6661Fax+1 650-498-6205- Is this information wrong?
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 2014 - 2018- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2012 - 2014
Stanford University School of MedicineClass of 2010
Certifications & Licensure
CA State Medical License 2013 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 1 citations5-Azacytidine depletes HSCs and synergizes with an anti-CD117 antibody to augment donor engraftment in immunocompetent mice.Andriyana K Bankova, Wendy W. Pang, Brenda J. Velasco, Janel Long-Boyle, Judith A. Shizuru> ;Blood Advances. 2021 Oct 12
- 12 citationsRUNX3 levels in human hematopoietic progenitors are regulated by aging and dictate erythroid-myeloid balance.Peter Balogh, Emmalee R. Adelman, John V. Pluvinage, Brian J. Capaldo, Katie Freeman, Sandeep Singh, Kamaleldin E. Elagib, Yukio Nakamura, Ryo Kurita, Goro Sashida, El...> ;Haematologica. 2020 Apr 1
- 3 citationsBlockade of TIM-1 on the donor graft ameliorates graft-versus-host disease following hematopoietic cell transplantation.Bettina P. Iliopoulou, Katie Hsu, Magdiel Pérez-Cruz, Sai-Wen Tang, Wendy W. Pang, Tom Erkers, Neeraja Kambham, Gordon J. Freeman, Rosemarie H. DeKruyff, Everett Meyer> ;Blood Advances. 2019 Nov 12
- Join now to see all
Press Mentions
Jasper Therapeutics Initiates New Clinical Trial with National Cancer Institute to Evaluate JSP191 in GATA2-Related Myelodysplastic SyndromesSeptember 8th, 2021- Jasper Therapeutics Announces Positive Data from Phase 1 Clinical Trial of JSP191 as Targeted Stem Cell Conditioning Agent in Patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia Undergoing Hematopoietic Cell TransplantationFebruary 8th, 2021
Antibody Could Increase Cure Rate for Blood, Immune DisordersFebruary 11th, 2019
Hospital Affiliations
Stanford Health CarePalo Alto, California
Lucile Packard Children's Hospital StanfordPalo Alto, California
Santa Clara Valley Medical CenterSan Jose, California
VA Palo Alto Heath CarePalo Alto, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
